> ## Documentation Index
> Fetch the complete documentation index at: https://docs.hi-doctor.ai/llms.txt
> Use this file to discover all available pages before exploring further.

# Orlistat 120mg (alli)

> How orlistat blocks fat absorption in the gut, what XENDOS and the European Multicentre study reported, and the bowel side effects to expect.

Orlistat is a capsule swallowed with meals. It is not a hormone and does not
act on the brain or on appetite — it blocks the gut enzymes that digest fat,
so roughly a third of the fat in a meal leaves the body in the stool instead
of being absorbed. In the EU it is sold as Xenical and taken alongside a
slightly reduced-calorie, lower-fat diet.

<Note>
  **Orlistat 120mg vs. alli.** This page covers the prescription-strength
  120 mg capsule (Xenical) that Hi-Doctor's doctors review. alli is the
  pharmacy version of orlistat that can be bought without a prescription —
  each alli capsule contains half the orlistat dose of the prescription-only
  120 mg product. alli is centrally authorised across the EU, and the
  authorisation is held by Haleon Ireland Dungarvan Limited.
</Note>

## What it is

<CardGroup cols={2}>
  <Card title="Active ingredient" icon="flask">
    Orlistat — a lipase inhibitor taken as a hard capsule that acts only
    inside the gut.
  </Card>

  <Card title="Dosage" icon="pills">
    120 mg with each main meal, up to three capsules a day.
  </Card>
</CardGroup>

Orlistat is authorised in the EU for weight loss in adults with obesity,
alongside a mildly reduced-calorie diet, and specifically for a body mass
index of 28 kg/m² or more, taken together with a mildly reduced-calorie,
lower-fat diet. It has been authorised for use in the EU since 29 July 1998,
so a licensed doctor can prescribe it when it is clinically appropriate.

## How it works

<CardGroup cols={3}>
  <Card title="It switches off fat-digesting enzymes" icon="lock">
    Orlistat blocks the enzymes in the stomach and gut that break down fat,
    so about a third of the fat in a meal passes through the body instead of
    being absorbed.
  </Card>

  <Card title="Dietary fat stays undigested" icon="droplet">
    The inactivated enzyme cannot break dietary fat, which arrives as
    triglycerides, into the smaller free fatty acids and monoglycerides that
    the gut wall can take up. The fat stays whole, and whole fat molecules
    are too large to cross into the body.
  </Card>

  <Card title="The blocked fat leaves in stool" icon="route">
    The unabsorbed fat passes along the bowel and out in the stool, so those
    calories never reach the body. The European Medicines Agency describes
    the 120 mg dose as letting about 30% of the fat eaten in a meal pass
    through undigested.
  </Card>
</CardGroup>

Unlike GLP-1 medicines, orlistat does not act on appetite — its effect
depends on keeping to an appropriate diet while taking it. It is a valid
alternative for people who cannot or do not want injectable treatments,
although average weight loss is usually lower.

<CardGroup cols={3}>
  <Card title="No injections" icon="syringe">
    A capsule, not an injection.
  </Card>

  <Card title="Local, not systemic" icon="stomach">
    Acts locally in the gut, not system-wide.
  </Card>

  <Card title="Adjunct to diet" icon="utensils">
    An alternative when GLP-1s aren't the right fit.
  </Card>
</CardGroup>

## What the studies reported

<Tabs>
  <Tab title="XENDOS">
    XENDOS was designed to test prevention of type 2 diabetes rather than
    weight loss alone. Only 52% of the orlistat group and 34% of the placebo
    group completed the four years, and everyone in the trial also made
    lifestyle changes (Diabetes Care 2004;27(1):155-161).
  </Tab>

  <Tab title="European Multicentre Orlistat Study">
    Published in The Lancet 1998;352(9123):167-17203068-4).
  </Tab>
</Tabs>

Every trial behind orlistat is grouped by source and evidence grade, so
journal data and manufacturer announcements are not confused.

## Who it is not suitable for

A doctor checks medical history and current medication before prescribing.
Yellowing skin can signal serious liver injury and should always be reported.
Orlistat is not suitable for people with chronic malabsorption syndrome or
cholestasis.

## Interactions

Because orlistat blocks fat absorption, it can interfere with the absorption
of other medicines taken at the same time. The EU Summary of Product
Characteristics advises that orlistat and cyclosporine should not be taken
together, and that thyroid medicines, warfarin and some anti-epileptic
medicines may need dose adjustment. The reviewing doctor checks current
medication before prescribing.

## What happens when you stop

Because orlistat works only while it is in the gut, stopping means normal fat
digestion resumes. Weight that was lost during treatment can be regained if
the dietary changes made alongside it are not sustained.

## Common questions

<AccordionGroup>
  <Accordion title="Can I take orlistat if I am already taking a GLP-1 medicine?">
    Orlistat and GLP-1 medicines work through completely different mechanisms
    — one in the gut, one through hormone signalling. A doctor reviews whether
    combining them is appropriate for your case, but the two are not routinely
    prescribed together.
  </Accordion>

  <Accordion title="How long does it take to see results with orlistat?">
    The effect on fat absorption starts with the first capsule taken with a
    fatty meal. Weight change is reviewed at month 3 by the doctor, as the
    first meaningful assessment point.
  </Accordion>

  <Accordion title="Do I need to follow a special diet with orlistat?">
    Yes. Orlistat is authorised alongside a mildly reduced-calorie, lower-fat
    diet. The bowel effects are more likely after a fatty meal, so adjusting
    meals towards lower fat from day 1 is part of the approach.
  </Accordion>

  <Accordion title="Can I take a multivitamin with orlistat?">
    Orlistat can reduce absorption of vitamins A, D, E and K. The EU product
    information advises a diet rich in fruit and vegetables and says a
    multivitamin supplement taken at bedtime may be considered.
  </Accordion>

  <Accordion title="Is orlistat safe to take long-term?">
    Orlistat has been authorised for use in the EU since 29 July 1998, with
    long-term safety data from the XENDOS trial that followed people for four
    years. The doctor reviews response at month 3 and periodically thereafter.
  </Accordion>
</AccordionGroup>

## What has been reported

The EU Summary of Product Characteristics lists these bowel effects at the
120 mg dose:

| Effect                                                                                     | Frequency                                    |
| ------------------------------------------------------------------------------------------ | -------------------------------------------- |
| Oily spotting, fatty/oily stools, wind with discharge, urgent or increased bowel movements | Very common (more than 1 in 10 people)       |
| Abdominal pain or discomfort, flatulence, liquid stools                                    | Very common (more than 1 in 10 people)       |
| Faecal incontinence, soft stools                                                           | Common (between 1 in 100 and 1 in 10 people) |
| Headache                                                                                   | Very common (more than 1 in 10 people)       |

These bowel effects are more likely after a fatty meal, because the
undigested fat has to go somewhere.

<Warning>
  Orlistat can reduce absorption of vitamins A, D, E and K. The EU product
  information advises a diet rich in fruit and vegetables, and says a
  multivitamin supplement — taken at bedtime — may be considered.
</Warning>

## How Hi-Doctor handles it

A questionnaire covering weight, medical history, current medication and
previous weight-loss treatment feeds into the doctor's decision — see how
[eligibility works](/essentials/how-it-works). Orlistat is one of several
[weight-loss options](/essentials/treatments) a doctor may consider,
alongside injectable medicines like [Mounjaro](/library/medicines/mounjaro)
and [Wegovy](/library/medicines/wegovy). For the 120 mg prescription version,
see [orlistat (Xenical)](/library/medicines/orlistat). The medical
consultation cost is set out on [pricing](/essentials/pricing); the medicine
itself is paid separately at a pharmacy. See also
[safety and eligibility](/essentials/safety) for the full checks a doctor
applies.

## Start a consultation

<Card title="Weight-loss consultation" icon="stethoscope" href="https://hi-doctor.ai/consultation/weight-loss/1">
  Answer the weight-loss questionnaire and a registered doctor reviews it.
  They decide whether treatment is appropriate, which one, and at what dose —
  and declining is a normal outcome. See [what it costs](/essentials/pricing)
  and [how the review works](/essentials/how-it-works).
</Card>

<Warning>
  This page is reference information, not medical advice and not a prescription.
  Whether a medicine is appropriate for you is decided by a registered doctor
  after reviewing your consultation.
</Warning>
